Transcriptomic profile of epileptic children treated with ketogenic therapies

Background: Ketogenic dietary therapies (KDT) are used as a treatment in childhood epilepsy. However, their mechanism has not yet been established. The main objective of this study was to determine the changes in the transcriptomic profile induced by KDT in children with epilepsy in order to shed...

Full description

Bibliographic Details
Main Authors: Jana Ruiz-Herrero, Gloria Olaso-Gonzalez, Eva Serna, Elvira Cañedo-Villarroya, Angela G. Correas, Juan Gambini, Mari Carmen Gomez-Cabrera, Consuelo Pedrón-Giner, Jose Vina
Format: Article
Language:English
Published: IMR Press 2022-01-01
Series:Journal of Integrative Neuroscience
Subjects:
Online Access:https://article.imrpress.com/journal/JIN/21/1/10.31083/j.jin2101031/1757-448X-21-1-031.pdf
_version_ 1811291395266183168
author Jana Ruiz-Herrero
Gloria Olaso-Gonzalez
Eva Serna
Elvira Cañedo-Villarroya
Angela G. Correas
Juan Gambini
Mari Carmen Gomez-Cabrera
Consuelo Pedrón-Giner
Jose Vina
author_facet Jana Ruiz-Herrero
Gloria Olaso-Gonzalez
Eva Serna
Elvira Cañedo-Villarroya
Angela G. Correas
Juan Gambini
Mari Carmen Gomez-Cabrera
Consuelo Pedrón-Giner
Jose Vina
author_sort Jana Ruiz-Herrero
collection DOAJ
description Background: Ketogenic dietary therapies (KDT) are used as a treatment in childhood epilepsy. However, their mechanism has not yet been established. The main objective of this study was to determine the changes in the transcriptomic profile induced by KDT in children with epilepsy in order to shed light on its possible mechanisms. Methods: Eight children with refractory epilepsy were enrolled in the study. Peripheral blood mononuclear cells were obtained before and after the children were treated with KDT for a minimum of 6 months. RNA was extracted and mRNA and miRNA profiling were performed and analyzed. Results: Our intervention with KDT significantly reduced the seizure number in seven of the eight paediatric patients treated and caused important changes in their gene expression profile. Our study reveals modifications in the transcription of 4630 genes and 230 miRNAs. We found that the genes involved in the protection against epileptic crises were among those mainly changed. These genes collectively encode for ion channels, neurotransmitter receptors, and synapse structural proteins. Conclusions: Together our results explain the possible mechanisms of KDT and reinforce its clinical importance in the treatment of epilepsy.
first_indexed 2024-04-13T04:28:12Z
format Article
id doaj.art-985b98d3bec042bc816164a1321ed42c
institution Directory Open Access Journal
issn 0219-6352
language English
last_indexed 2024-04-13T04:28:12Z
publishDate 2022-01-01
publisher IMR Press
record_format Article
series Journal of Integrative Neuroscience
spelling doaj.art-985b98d3bec042bc816164a1321ed42c2022-12-22T03:02:25ZengIMR PressJournal of Integrative Neuroscience0219-63522022-01-0121103110.31083/j.jin2101031S0219-6352(22)00291-1Transcriptomic profile of epileptic children treated with ketogenic therapiesJana Ruiz-Herrero0Gloria Olaso-Gonzalez1Eva Serna2Elvira Cañedo-Villarroya3Angela G. Correas4Juan Gambini5Mari Carmen Gomez-Cabrera6Consuelo Pedrón-Giner7Jose Vina8Department of Pediatric Gastroenterology, Pediatric Service, San Rafael Hospital, 2016 Madrid, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainDepartment of Gastroenterology and Nutrition, Niño Jesús Pediatric Hospital, 28009 Madrid, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainDepartment of Gastroenterology and Nutrition, Niño Jesús Pediatric Hospital, 28009 Madrid, SpainFreshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, SpainBackground: Ketogenic dietary therapies (KDT) are used as a treatment in childhood epilepsy. However, their mechanism has not yet been established. The main objective of this study was to determine the changes in the transcriptomic profile induced by KDT in children with epilepsy in order to shed light on its possible mechanisms. Methods: Eight children with refractory epilepsy were enrolled in the study. Peripheral blood mononuclear cells were obtained before and after the children were treated with KDT for a minimum of 6 months. RNA was extracted and mRNA and miRNA profiling were performed and analyzed. Results: Our intervention with KDT significantly reduced the seizure number in seven of the eight paediatric patients treated and caused important changes in their gene expression profile. Our study reveals modifications in the transcription of 4630 genes and 230 miRNAs. We found that the genes involved in the protection against epileptic crises were among those mainly changed. These genes collectively encode for ion channels, neurotransmitter receptors, and synapse structural proteins. Conclusions: Together our results explain the possible mechanisms of KDT and reinforce its clinical importance in the treatment of epilepsy.https://article.imrpress.com/journal/JIN/21/1/10.31083/j.jin2101031/1757-448X-21-1-031.pdfepilepsyketogenic dietketogenic dietary therapiestranscriptomeanticonvulsantsynapsismirnome
spellingShingle Jana Ruiz-Herrero
Gloria Olaso-Gonzalez
Eva Serna
Elvira Cañedo-Villarroya
Angela G. Correas
Juan Gambini
Mari Carmen Gomez-Cabrera
Consuelo Pedrón-Giner
Jose Vina
Transcriptomic profile of epileptic children treated with ketogenic therapies
Journal of Integrative Neuroscience
epilepsy
ketogenic diet
ketogenic dietary therapies
transcriptome
anticonvulsant
synapsis
mirnome
title Transcriptomic profile of epileptic children treated with ketogenic therapies
title_full Transcriptomic profile of epileptic children treated with ketogenic therapies
title_fullStr Transcriptomic profile of epileptic children treated with ketogenic therapies
title_full_unstemmed Transcriptomic profile of epileptic children treated with ketogenic therapies
title_short Transcriptomic profile of epileptic children treated with ketogenic therapies
title_sort transcriptomic profile of epileptic children treated with ketogenic therapies
topic epilepsy
ketogenic diet
ketogenic dietary therapies
transcriptome
anticonvulsant
synapsis
mirnome
url https://article.imrpress.com/journal/JIN/21/1/10.31083/j.jin2101031/1757-448X-21-1-031.pdf
work_keys_str_mv AT janaruizherrero transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT gloriaolasogonzalez transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT evaserna transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT elviracanedovillarroya transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT angelagcorreas transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT juangambini transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT maricarmengomezcabrera transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT consuelopedronginer transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies
AT josevina transcriptomicprofileofepilepticchildrentreatedwithketogenictherapies